about
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionSpatiotemporal Dynamics of Insulitis in Human Type 1 DiabetesMechanisms of Autoantibody-Induced Pathology.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigationAutoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesisGene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsRisk of inflammatory bowel disease according to self-rated health, pregnancy course, and pregnancy complications: a study within the Danish National Birth Cohort.Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes.The effect of the MHC locus on autoantibodies in type 1 diabetesEtiopathogenesis of insulin autoimmunity.Study on Genetic Variance of miR-541 in Type 1 DiabetesThe pathogenesis and natural history of type 1 diabetes.Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic MiceThe Control of Stress Induced Type I Diabetes Mellitus in Humans through the Hepatic Synthesis of Insulin by the Stimulation of Nitric Oxide ProductionAutoantibodies and neurodegeneration in multiple sclerosis.No association of multiple type 2 diabetes loci with type 1 diabetes.CD40 and autoimmunity: the dark side of a great activator.ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onsetInducing immune tolerance: a focus on Type 1 diabetes mellitus.Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunityB cell depletion in autoimmune diabetes: insights from murine models.The potential of multimer technologies in type 1 diabetes prediction strategies.Psychological impact of screening and prediction in type 1 diabetes.The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.Molecular mechanisms in autoimmune type 1 diabetes: a critical review.Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.Functional cytotoxic T lymphocytes against IGRP206-214 predict diabetes in the non-obese diabetic mouse.A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes?The role of Dermcidin isoform-2 in the occurrence and severity of DiabetesAnti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice.Mycobacterium avium subsp. paratuberculosis in an Italian cohort of type 1 diabetes pediatric patients.Autoantibodies against aminoacyl-tRNA synthetase: novel diagnostic marker for type 1 diabetes mellitus.Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies.Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes.Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.
P2860
Q24299570-7C7699D2-1CA2-4E4C-A5A5-20FC913DA4E8Q30833054-80E847E7-A6D1-47D1-ADBE-AEDE4E943B5AQ33740580-74117C1C-8674-48D2-A08E-9C3FD769A1FAQ33890221-1FECA9E5-6EB1-4CF4-B770-DB7478C81F31Q34166421-050BE3FA-8011-4C33-898C-4774E1A2AD5FQ34259926-AB4F52E6-CFC9-4760-94F0-DFE99743B9A5Q34260546-5C76A17D-50AA-4B8C-80CE-FA44D626284AQ34635457-2AC66D8B-7085-454D-8072-915CBB82ACB5Q34982636-154ED1B7-B6DF-49E9-814B-6752BB8DDB74Q35053311-DD575FE9-99F3-4C28-B971-1C333EC63635Q35726979-D0379928-A12B-43EA-856B-1F3BDF901AE5Q35910119-8B3F778A-7CA9-4B75-9B75-291BF02BB017Q36488802-B98AF46C-0E96-4D8E-B7D0-A356B1F5FB5AQ36526611-86534AD8-24E0-4DEF-ABAA-2FA5DB62BD80Q36568311-BD22FF46-0C98-4C8F-A6F0-A49BC40345AAQ36736711-FAE3158F-E303-4843-A227-D8B30C9E37B2Q37180839-3C477A04-51AC-4324-8984-85DACB2B165BQ37335231-47EFEE38-1B76-404F-9659-707356BFE813Q37365433-C16B2F49-44AC-4AEA-B1CD-B72F1C90636BQ37520312-6B58F248-55B6-4C7B-963C-1483D3F30AF4Q37542678-C4A4F549-FD31-4CE4-8100-5EEF03F72080Q37704768-A0951D2E-FF52-4A00-98BF-492AE4C8B0BEQ37720217-D255BE8B-BC69-46CD-AB9D-0A75E5378EE4Q37838895-4CDB5CEF-352C-451D-ADFB-EDEFE715566FQ37895165-4164D496-AE1D-4FAE-9E6D-0548AECA6BE3Q38126109-81479846-FC98-43DD-9159-9B023707B8FDQ38206114-0184931F-3397-4662-B7A1-12A1C62F1713Q39015884-011D9E18-6028-49E0-8783-3CFED09B4B55Q39201989-62AB9348-6F54-455D-B69B-B7DB08D75310Q40951033-39BA95CA-C4F7-492E-8902-3FE51840F70EQ41341635-C579185E-1FD1-4096-A32D-9E10A7089010Q41422903-A64763BE-A998-4CE9-B030-AA1C0139FF3FQ41428260-22706591-4F21-49F7-985D-7DC88D14FD4AQ41787880-56F3E30B-12A5-4889-BF6B-8D195F919B73Q43080170-F1B9AAB5-216B-448E-A38D-73189FC19D21Q43738022-AFD20016-D107-4BE0-BC58-F4039EFAFE81Q45942661-8C070A74-C718-4CA0-BA61-5E0455214FAEQ46383363-F55608A6-C9C4-4218-B43E-6EB716068DD1Q47152844-681994CE-31E6-4246-B8D2-F3DFB1408B68Q49808758-3D2EAA66-AEFE-4A56-BD18-A49A0BBBF6C1
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Autoantibodies in type 1 diabetes.
@en
Autoantibodies in type 1 diabetes.
@nl
type
label
Autoantibodies in type 1 diabetes.
@en
Autoantibodies in type 1 diabetes.
@nl
prefLabel
Autoantibodies in type 1 diabetes.
@en
Autoantibodies in type 1 diabetes.
@nl
P2860
P1433
P1476
Autoantibodies in type 1 diabetes.
@en
P2093
Craig E Taplin
Jennifer M Barker
P2860
P356
10.1080/08916930701619169
P577
2008-02-01T00:00:00Z